Ferrous Sulfate

Ferrous sulfate, a common oral iron supplement, is being extensively studied in clinical trials for its effectiveness in treating iron deficiency anemia across various patient populations. These trials aim to compare ferrous sulfate with other iron formulations, evaluate different dosing regimens, and assess its efficacy in specific conditions such as chronic kidney disease, pregnancy, and heavy menstrual bleeding. The research seeks to optimize iron therapy while minimizing side effects and improving patient outcomes.

Table of Contents

What is Ferrous Sulfate?

Ferrous sulfate is a medication used to treat and prevent iron deficiency anemia. It is a form of iron that can be taken orally to increase the body’s iron levels. Ferrous sulfate is also known by other names such as Fer-in-Sol, Feratab, Feosol, and simply “iron”[1]. This medication is essential for people who don’t have enough iron in their bodies, which is necessary for producing hemoglobin, a protein in red blood cells that carries oxygen throughout the body.

Conditions Treated with Ferrous Sulfate

Ferrous sulfate is primarily used to treat and prevent the following conditions:

  • Iron Deficiency Anemia (IDA): This is the most common condition treated with ferrous sulfate. It occurs when the body doesn’t have enough iron to produce adequate hemoglobin[2].
  • Latent Iron Deficiency: This is a state where iron stores are depleted, but anemia has not yet developed[2].
  • Anemia in Chronic Kidney Disease (CKD): Patients with CKD often develop anemia and may benefit from iron supplementation[3].
  • Anemia in Pregnancy: Pregnant women have increased iron needs and may require supplementation to prevent or treat anemia[4].
  • Heavy Menstrual Bleeding: Women with heavy periods may develop iron deficiency and require supplementation[5].

How Ferrous Sulfate Works

Ferrous sulfate works by providing the body with elemental iron, which is essential for the production of hemoglobin. When you take ferrous sulfate, it is absorbed in the intestines and enters the bloodstream. From there, it is used to produce new red blood cells and increase hemoglobin levels. This process helps to alleviate symptoms of anemia such as fatigue, weakness, and shortness of breath[2].

Dosage and Administration

The dosage of ferrous sulfate can vary depending on the patient’s age, condition, and severity of iron deficiency. Some common dosing regimens include:

  • Daily dosing: Often prescribed as 325 mg (65 mg of elemental iron) once or twice daily[6].
  • Alternate day dosing: Some studies suggest taking iron every other day may improve absorption[5].
  • Weekly dosing: In some cases, especially for prevention, a weekly dose may be recommended[1].
  • For children: Dosing is usually based on weight, typically 3-6 mg/kg/day of elemental iron[3].

It’s important to take ferrous sulfate as directed by your healthcare provider. It is often recommended to take it on an empty stomach or between meals to improve absorption, but it can be taken with food if stomach upset occurs[7].

Effectiveness of Ferrous Sulfate

Ferrous sulfate has been shown to be effective in treating and preventing iron deficiency anemia. Studies have demonstrated improvements in hemoglobin levels, serum ferritin (a measure of iron stores), and overall iron status in patients taking ferrous sulfate[2]. However, the effectiveness can vary depending on the individual and the underlying cause of iron deficiency.

Potential Side Effects

While ferrous sulfate is generally well-tolerated, some patients may experience side effects. Common side effects include:

  • Gastrointestinal discomfort
  • Nausea
  • Vomiting
  • Diarrhea
  • Constipation
  • Dark stools

These side effects are often mild and may improve over time. Taking the medication with food or adjusting the dosing schedule can sometimes help reduce these effects[4].

Alternative Treatments and Comparisons

While ferrous sulfate is a common treatment for iron deficiency, there are other options available:

  • Lactoferrin: Some studies have investigated the use of bovine lactoferrin as an alternative to ferrous sulfate, particularly in pregnant women. Lactoferrin may have fewer side effects and potentially anti-inflammatory properties[4].
  • Other iron formulations: Different forms of iron, such as ferrous gluconate or ferrous fumarate, may be used in some cases.
  • Intravenous iron: For patients who cannot tolerate oral iron or have severe anemia, intravenous iron may be recommended.

Use in Special Populations

Ferrous sulfate is used in various patient populations, but special considerations may apply:

  • Pregnant women: Iron supplementation is often necessary during pregnancy, but dosing and timing may need to be adjusted[4].
  • Children and adolescents: Dosing is typically based on weight, and different formulations (like drops or liquid) may be used[3].
  • Patients with chronic kidney disease: Iron supplementation is common in CKD patients, but dosing and monitoring may differ from the general population[3].

Always consult with your healthcare provider before starting or changing any iron supplementation regimen. They can provide personalized advice based on your specific health needs and conditions.

Patient Group Intervention Comparison Key Outcomes
Infants with latent iron deficiency Ferrous sulfate supplemented milk Blédilait Biofer® milk Serum ferritin, red blood cell count
Adolescents with heavy menstrual bleeding Daily vs. alternate-day ferrous sulfate Standard daily dosing Hemoglobin, iron absorption, side effects
Pregnant women with hereditary thrombophilia Ferrous sulfate Bovine lactoferrin Hematological parameters, inflammatory markers
Children with chronic kidney disease Oral ferrous sulfate No iron therapy Muscle strength, transferrin saturation, quality of life
Adults with chronic kidney disease Various dosing regimens of ferrous sulfate Daily vs. alternate-day vs. thrice daily Hemoglobin levels, iron parameters

Ongoing Clinical Trials on Ferrous Sulfate

  • Study on Treating Anemia After Cesarean with Ferric Carboxymaltose or Oral Iron in Women with Moderate Iron Deficiency Anemia

    Recruiting

    3 1 1 1
    France
  • Feasibility, Tolerability and Adherence of Alternate-Day Ferrous Sulfate (Duroferon) in Adolescent Girls With Iron Deficiency

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden

Glossary

  • Ferrous sulfate: A form of iron supplement commonly used to treat or prevent iron deficiency anemia. It is taken orally and helps increase iron levels in the body.
  • Iron deficiency anemia: A condition where there is a lack of healthy red blood cells due to insufficient iron in the body. This can cause fatigue, weakness, and other symptoms.
  • Hemoglobin: A protein in red blood cells that carries oxygen throughout the body. It is often measured to assess anemia.
  • Serum ferritin: A blood protein that contains iron. Its levels are often used to evaluate iron stores in the body.
  • Transferrin saturation: A measure of how much iron is bound to transferrin (a protein that transports iron in the blood). It helps assess iron status.
  • Chronic kidney disease (CKD): A condition characterized by gradual loss of kidney function over time, which can affect iron metabolism and lead to anemia.
  • Lactoferrin: An iron-binding protein being studied as an alternative to traditional iron supplements for treating anemia.
  • Hepcidin: A hormone that regulates iron absorption and distribution in the body. Its levels can affect iron metabolism.
  • Biofer®: A specialized iron compound used in some infant milk formulas being studied for treating iron deficiency.
  • Hereditary thrombophilia: A genetic condition that increases the risk of blood clots, which can complicate iron therapy during pregnancy.

References

  1. https://clinicaltrials.gov/study/NCT03359447
  2. https://clinicaltrials.gov/study/NCT00554814
  3. https://clinicaltrials.gov/study/NCT03991169
  4. https://clinicaltrials.gov/study/NCT01221844
  5. https://clinicaltrials.gov/study/NCT05007899
  6. https://clinicaltrials.gov/study/NCT03940430
  7. https://clinicaltrials.gov/study/NCT06521216